Embecta Corp. (EMBC)
- Previous Close
11.66 - Open
11.66 - Bid 12.00 x 300
- Ask 12.06 x 300
- Day's Range
11.63 - 12.19 - 52 Week Range
10.83 - 21.48 - Volume
531,298 - Avg. Volume
602,358 - Market Cap (intraday)
702.479M - Beta (5Y Monthly) 1.19
- PE Ratio (TTM)
13.51 - EPS (TTM)
0.89 - Earnings Date Aug 7, 2025 - Aug 11, 2025
- Forward Dividend & Yield 0.60 (4.99%)
- Ex-Dividend Date May 28, 2025
- 1y Target Est
18.50
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
www.embecta.com2,000
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: EMBC
View MorePerformance Overview: EMBC
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EMBC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EMBC
View MoreValuation Measures
Market Cap
702.48M
Enterprise Value
2.04B
Trailing P/E
13.51
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.65
Price/Book (mrq)
--
Enterprise Value/Revenue
1.89
Enterprise Value/EBITDA
9.88
Financial Highlights
Profitability and Income Statement
Profit Margin
4.89%
Return on Assets (ttm)
2.53%
Return on Equity (ttm)
--
Revenue (ttm)
1.08B
Net Income Avi to Common (ttm)
52.8M
Diluted EPS (ttm)
0.89
Balance Sheet and Cash Flow
Total Cash (mrq)
209.3M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-50.65M